Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
5
-
Share change
-
0
-
Total reported value
-
$173
-
Price per share
-
$34.60
-
Number of holders
-
1
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2021
As of 30 Jun 2021,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
5 shares.
The largest 1 holders included
Sofos Investments, Inc..
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.